A Phase 1 Multi-Dose Study of Human Placental Hematopoietic Stem Cell Derived Natural Killer Cells (CYNK-001) in Adults with Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission with Minimal Residual Disease (MRD) (NCT04310592)
2021 ◽
Vol 27
(3)
◽
pp. S161-S162
2018 ◽
Vol 25
(6)
◽
pp. 425-432
◽
2016 ◽
Vol 58
(5)
◽
pp. 1135-1143
◽
2018 ◽
Vol 23
(11)
◽
pp. 1349-1357
◽
2011 ◽
Vol 18
(6)
◽
pp. 381-387
◽
2021 ◽
Vol 27
(3)
◽
pp. S130-S131
2019 ◽
Vol 54
(12)
◽
pp. 1987-1994
◽
2019 ◽
Vol 25
(10)
◽
pp. 1925-1932
◽